Evidence map›Paper›PMID 40247875›Full record

ArticleFrontiers in public health2025

Who benefits? Health equity and the Translational Science Benefits Model.

Anna La Manna, Julie Heidbreder, Shannon Casey, Kat Phelps, Mia LaBrier, Laura Brossart, Ella Clark, Emmanuel Tetteh, Sara Malone, Douglas A Luke and 1 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Application of a Conceptual Model for Translational Science Impact.Journal of clinical and translational science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna La MannaCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Julie HeidbrederCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Shannon CaseySchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.
Kat PhelpsSchool of Nursing, University of Wisconsin-Madison, Madison, WI, United States.
Mia LaBrierCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Laura BrossartCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Ella ClarkCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Emmanuel TettehCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Sara MaloneCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Douglas A LukeCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.
Todd CombsCenter for Public Health Systems Science, Washington University in St. Louis, St. Louis, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Evaluating the impacts of translational science is crucial for demonstrating the quality, relevance, and societal benefits of research. This paper presents current results of efforts to expand the Translational Science Benefits Model (TSBM), a framework and toolkit originally developed at Washington University in St. Louis with 30 specific, real-world benefits across clinical, community, economic, and policy domains. In response to a growing emphasis on health and social equity, we have refined the TSBM to better address and integrate ideas of fairness and justice. Methods: Our methods included a literature scan to identify health equity gaps in the framework, community listening sessions in St. Louis, MO, and Madison, WI, and thematic analysis to incorporate equity into the TSBM. Results: The results introduce new dimensions within the existing TSBM domains that include 10 new benefits, all emphasizing themes of trust, power, and access. Discussion: Our aim is to enhance the relevance and utility of the framework and tools to researchers, practitioners, and those affected by implementations of findings from translational science and research. The integration of equity into the TSBM supports continued growth in the number of users and uses of the framework and toolkit to demonstrate health and social impact.

Indexed as

Health EquityTranslational Research, BiomedicalTranslational Science, BiomedicalHumanscommunity engagementframeworkhealth equityimpact evaluationtranslational science

Identifiers

PMID40247875
PMCPMC12003293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.